- Home
- DTIL vs TORO Comparison
DTIL vs TORO Comparison
Compare DTIL & TORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DTIL | TORO |
|---|---|---|
| Founded | 2006 | 2022 |
| Country | United States | Cyprus |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.3M | 173.8M |
| IPO Year | 2019 | 2022 |
Fundamental Metrics
Financial Performance| Metric | DTIL | TORO |
|---|---|---|
| Price | $8.22 | $5.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $45.00 | N/A |
| AVG Volume (30 Days) | ★ 488.0K | 39.5K |
| Earning Date | 05-14-2026 | 04-15-2026 |
| Dividend Yield | N/A | ★ 36.86% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,070,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.53 | $2.12 |
| 52 Week High | $8.82 | $8.50 |
Technical Indicators
Market Signals| Indicator | DTIL | TORO |
|---|---|---|
| Relative Strength Index (RSI) | 67.70 | 50.46 |
| Support Level | $6.30 | $4.93 |
| Resistance Level | $8.70 | $5.85 |
| Average True Range (ATR) | 0.49 | 0.28 |
| MACD | 0.19 | 0.01 |
| Stochastic Oscillator | 93.44 | 54.11 |
Price Performance
Historical ComparisonAbout DTIL Precision BioSciences Inc.
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
About TORO Toro Corp.
Toro Corp is engaged in the acquisition, ownership, chartering, and operation of oceangoing tanker and LPG carrier vessels, providing seaborne transportation services for crude oil, refined petroleum products, and liquefied petroleum gas. The company operates through three segments: the Eco tanker segment, the Non-Eco tanker segment, and the LPG carrier segment. It generates the majority of its revenue from the LPG carrier segment.